The regulation of CD5 expression in murine T cells

BMC Molecular Biology

Volumn 2, Issue , 2001, Pages

  Tung, James W ^a   Kunnavatana, Shaun S ^a   Herzenberg, Leonard A ^a   Herzenberg, Leonore A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD5 ANTIGEN; LUCIFERASE; TRANSCRIPTION FACTOR ETS 1;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; BINDING SITE; CELL LEVEL; CONTROLLED STUDY; GEL MOBILITY SHIFT ASSAY; GENE CONTROL; GENE EXPRESSION REGULATION; GENETIC CONSERVATION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; MOLECULAR RECOGNITION; NONHUMAN; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN FAMILY; PROTEIN LOCALIZATION; REPORTER GENE; T LYMPHOCYTE; THYMOMA; TRANSCRIPTION REGULATION; TUMOR CELL;

MURINAE;

EID: 2542476264     PISSN: 14712199     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2199-2-5     Document Type: Article

References (49)

1. Huang HJ, Jones NH, Strominger JL, Herzenberg LA: Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells: molecular homology to its human counterpart Leu-1/T1 (CD5). Proc Natl Acad Sci U S A 1987, 84:204-208
2. Hayakawa K, Hardy RR, Parks DR, Herzenberg LA: The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med 1983, 157:202-218
3. Kantor AB, Herzenberg LA: Origin of murine B cell lineages. Annu Rev Immunol 1993, 11:501-538
4. Herzenberg LA, Stall AM, Lalor PA, Sidman C, Moore WA, Parks DR, Herzenberg LA: The Ly-1 B cell lineage. Immunol Rev 1986, 93:81-102
5. Tung JW: Molecular characterization of CD5 expression: study of the murine CD5 promoter. Stanford University; Thesis. 1997
6. Azzam HS, Grinberg A, Lui K, Shen H, Shores EW, Love PE: CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J Exp Med 1998, 188:2301-2311
7. Resnick D, Pearson A, Krieger M: The SRCR superfamily: a family reminiscent of the Ig superfamily. Trends Biochem Sci 1994, 19:5-8
8. Van de Velde H, von Hoegen I, Luo W, Parnes JR, Thielemans K: The B-cell surface protein CD72/Lyb-2 is the ligand for CD5. Nature 1991, 351:662-665
9. Biancone L, Bowen MA, Lim A, Aruffo A, Andres G, Stamenkovic I: Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes. J Exp Med 1996, 184:811-819
10. Pospisil R, Fitts MG, Mage RG: CD5 is a potential selecting ligand for B cell surface immunoglobulin framework region sequences. J Exp Med 1996, 184:1279-1284
11. Beyers AD, Spruyt LL, Williams AF: Molecular associations between the T-lymphocyte antigen receptor complex and the surface antigens CD2, CD4, or CD8 and CD5. Proc Natl Acad Sci U S A 1992, 89:2945-2949
12. Burgess KE, Yamamoto M, Prasad KV, Rudd CE: CD5 acts as a tyrosine kinase substrate within a receptor complex comprising T-cell receptor zeta chain/CD3 and protein-tyrosine kinases p56lck and p59fyn. Proc Natl Acad Sci U S A 1992, 89:9311-9315
13. Lankester AC, van SG, Cordell JL, van NC, van LR: CD5 is associated with the human B cell antigen receptor complex. Eur J Immunol 1994, 24:812-816
14. June CH, Rabinovitch PS, Ledbetter JA: CD5 antibodies increase intracellular ionized calcium concentration in T cells. J Immunol 1987, 138:2782-2792
15. Ceuppens JL, Baroja ML: Monoclonal antibodies to the CD5 antigen can provide the necessary second signal for activation of isolated resting T cells by solid-phase- bound OKT3. J Immunol 1986, 137:1816-1821
16. Ledbetter JA, June CH, Grosmaire LS, Rabinovitch PS: Crosslinking of surface antigens causes mobilization of intracellular ionized calcium in T lymphocytes. Proc Natl Acad Sci U S A 1987, 84:1384-1388
17. Tarakhovsky A, Kanner SB, Hombach J, Ledbetter JA, Muller W, Killeen N, Rajewsky K: A role for CD5 in TCR-mediated signal transduction and thymocyte selection. Science 1995, 269:535-537
18. Bikah G, Carey J, Ciallella JR, Tarakhovsky A, Bondada S: CD5-mediated negative regulation of antigen receptor-induced growth signals in B-1 B cells. Science 1996, 274:1906-1909
19. Reth M: Antigen receptor tail clue [letter]. Nature 1989, 338:383-384
20. Unkeless JC, Jin J: Inhibitory receptors, ITIM sequences and phosphatases. Curr Opin Immunol 1997, 9:338-343
21. Davies AA, Ley SC, Crumpton MJ: CD5 Is Phosphorylated on Tyrosine After Stimulation of the T-Cell Antigen Receptor Complex. Proc Natl Acad Sci USA 1992, 89:6368-6372
22. Raab M, Yamamoto M, Rudd CE: The T-cell antigen CD5 acts as a receptor and substrate for the protein- tyrosine kinase p56lck. Mol Cell Biol 1994, 14:2862-2870
23. Perez-Villar JJ, Whitney GS, Bowen MA, Hewgill DH, Aruffo AA, Kanner SB: CD5 negatively regulates the T-cell antigen receptor signal transduction pathway: involvement of SH2-containing phosphotyrosine phosphatase SHP-1. Mol Cell Biol 1999, 19:2903-2912
24. Gary-Gouy H, Bruhns P, Schmitt C, Dalloul A, Daeron M, Bismuth G: The pseudo-immunoreceptor tyrosine-based activation motif of CD5 mediates its inhibitory action on B-cell receptor signaling. J Biol Chem 2000, 275:548-556
25. Weichert TR, Schwartz RC: Cloning of the murine CD5 promoter and its tissue-specific regulation. J Immunol 1995, 154:4603-4612
26. Calvo J, Sole J, Simarro M, Vives J, Lozano F: Evolutionarily conserved transcription regulatory elements within the 5'-flanking region of the human CD5 gene. Tissue Antigens 1996, 47:257-261
27. Nye JA, Petersen JM, Gunther CV, Jonsen MD, Graves BJ: Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif. Genes Dev 1992, 6:975-990
28. Gunther CV, Nye JA, Bryner RS, Graves BJ: Sequence-specific DNA binding of the proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus. Genes Dev 1990, 4:667-679
29. Bhat NK, Komschlies KL, Fujiwara S, FisherO RJ, Mathieson BJ, Gregorio TA, Young HA, Kasik JW, Ozato K, Papas TS: Expression of ets genes in mouse thymocyte subsets and T cells. J Immunol 1989, 142:672-678
30. Muthusamy N, Barton K, Leiden JM: Defective activation and survival of T cells lacking the Ets-1 transcription factor. Nature 1995, 377:639-642
31. Bories JC, Willerford DM, Grevin D, Davidson L, Camus A, Martin P, Stehelin D, Alt FW: Increased T-cell apoptosis and terminal B-cell differentiation induced by inactivation of the Ets-1 proto-oncogene. Nature 1995, 377:635-638
32. Huang HS: Molecular cloning and characterization of the murine lymphocyte differentiation antigen Ly1-1 (murine CD5).Stanford University; 1987
33. Jonsen MD, Petersen JM, Xu QP, Graves BJ: Characterization of the cooperative function of inhibitory sequences in Ets-1. Mol Cell Biol 1996, 16:2065-2073
34. Hagman J, Grosschedl R: An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene. Proc Natl Acad Sci U S A 1992, 89:8889-8893
35. Klemsz MJ, McKercher SR, Celada A, Van Beveren C, Maki RA: The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene [see comments]. Cell 1990, 61:113-124
36. Hromas R, Orazi A, Neiman RS, Maki R, Van Beveran C, Moore J, Klemsz M: Hematopoietic lineage- and stage-restricted expression of the ETS oncogene family member PU.1. Blood 1993, 82:2998-3004
37. Kola I, Brookes S, Green AR, Garber R, Tymms M, Papas TS, Seth A: The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation. Proc Natl Acad Sci U S A 1993, 90:7588-7592
38. Maroulakou IG, Papas TS, Green JE: Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis. Oncogene 1994, 9:1551-1565
39. Weis L, Reinberg D: Transcription by RNA polymerase II: initiator-directed formation of transcription-competent complexes. Faseb J 1992, 6:3300-3309
40. Hariharan N, Perry RP: Functional dissection of a mouse ribosomal protein promoter: significance of the polypyrimidine initiator and an element in the TATA- box region. Proc Natl Acad Sci U S A 1990, 87:1526-1530
41. Roy AL, Meisterernst M, Pognonec P, Roeder RG: Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature 1991, 354:245-248
42. Seto E, Shi Y, Shenk T: YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro. Nature 1991, 354:241-245
43. Hariharan N, Kelley DE, Perry RP: Delta, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein. Proc Natl Acad Sci U S A 1991, 88:9799-9803
44. Verrijzer CP, Yokomori K, Chen JL, Tjian R: Drosophila TAFII150: similarity to yeast gene TSM-1 and specific binding to core promoter DNA. Science 1994, 264:933-941
45. Skalicky JJ, Donaldson LW, P etersen JM, Graves B J, McIntosh LP: Structural coupling of the inhibitory regions flanking the ETS domain of murine Ets-1. Protein Sci 1996, 5:296-309
46. Cong YZ, Rabin E, Wortis HH: Treatment of murine CD5- B cells with anti-Ig, but not LPS, induces surface CD5: two B-cell activation pathways. Int Immunol 1991, 3:467-476
47. Teutsch M, Higer M, Wang D, Wortis HW: Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK- 520 and rapamycin. Int Immunol 1995, 7:381-392
48. Berland R, Wortis HH: An NFAT-dependent enhancer is necessary for anti-IgM-mediated induction of murine CD5 expression in primary splenic B cells. J Immunol 1998, 161:277-285
49. Doody GM, Billadeau DD, Clayton E, Hutchings A, Berland R, McAdam S, Leibson PJ, Turner M: Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes. Embo J 2000, 19:6173-6184